INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $56,000 | +19.1% | 7,766 | 0.0% | 0.02% | +13.6% |
| Q1 2018 | $47,000 | -37.3% | 7,766 | 0.0% | 0.02% | -33.3% |
| Q4 2017 | $75,000 | -11.8% | 7,766 | -18.4% | 0.03% | -21.4% |
| Q3 2017 | $85,000 | -41.8% | 9,516 | -17.4% | 0.04% | -44.0% |
| Q2 2017 | $146,000 | +0.7% | 11,516 | -16.3% | 0.08% | -1.3% |
| Q1 2017 | $145,000 | +14.2% | 13,766 | 0.0% | 0.08% | +13.4% |
| Q4 2016 | $127,000 | +202.4% | 13,766 | +288.3% | 0.07% | +191.3% |
| Q3 2016 | $42,000 | -8.7% | 3,545 | 0.0% | 0.02% | -11.5% |
| Q2 2016 | $46,000 | -17.9% | 3,545 | +0.4% | 0.03% | -16.1% |
| Q1 2016 | $56,000 | -44.0% | 3,530 | +0.9% | 0.03% | -44.6% |
| Q4 2015 | $100,000 | 0.0% | 3,500 | 0.0% | 0.06% | -6.7% |
| Q3 2015 | $100,000 | -20.6% | 3,500 | 0.0% | 0.06% | -16.7% |
| Q2 2015 | $126,000 | +23.5% | 3,500 | +100.0% | 0.07% | +12.5% |
| Q1 2015 | $102,000 | +500.0% | 1,750 | +322.7% | 0.06% | +481.8% |
| Q4 2014 | $17,000 | – | 414 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 697,763 | $27,010,000 | 4.43% |
| Tamarack Capital Management, LLC | 235,000 | $9,097,000 | 2.15% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 196,117 | $7,591,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 132,862 | $6,093,000 | 0.36% |
| EMERALD ADVISERS, LLC | 118,242 | $4,577,000 | 0.25% |
| PDT Partners, LLC | 30,038 | $1,163,000 | 0.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 96,334 | $3,729,000 | 0.14% |
| Convergence Investment Partners, LLC | 17,450 | $675,000 | 0.11% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 122,556 | $4,744,000 | 0.11% |
| Spark Investment Management LLC | 13,992 | $541,000 | 0.09% |